RVAC Medicines
company
About
RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $140M
- Industries
- Biotechnology,Medical,Product Research
- Founded date
- Jan 1, 2021
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$140M
RVAC Medicines has raised a total of
$140M
in funding over 2 rounds. Their latest funding was raised on
Apr 26, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 26, 2022 | Series B | $140M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
RVAC Medicines has made 1 investments. Their most recent investment was on
Jul 4, 2021, when Trukkr raised $600K.
Investors
Number of Lead Investors
Number of Investors
—
1
RVAC Medicines is funded by 1 investors.
Pavilion Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pavilion Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
